Alyeska Investment Group, L.P. Generation Bio Co. Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding GBIO
# of Institutions
80Shares Held
48.9MCall Options Held
5.6KPut Options Held
100-
Price T Rowe Associates Inc Baltimore, MD9.28MShares$4.64 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC8.28MShares$4.14 Million1.45% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$1.65 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC3MShares$1.5 Million0.0% of portfolio
-
Siren, L.L.C. New York, NY2.98MShares$1.49 Million0.14% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $29.5M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...